The Woven Endobridge (WEB) device has been in clinical use for the treatment of brain aneurysms for the past 4 years. Observational studies to assess clinical outcome and related complications have been published. Clear evidence is required to better understand the safety profile of the WEB device. The authors here present a multicenter series that provides a detailed safety analysis focused on patient selection, procedural events, and technical issues of treated patients throughout the United Kingdom (UK).
A nationwide password-protected database was set up to collect anonymous information across the UK (14 centers). Complications and clinical outcome were analyzed for the initial 109 patients (112 procedures). An independent root cause analysis classified the complications into groups (procedural, disease, device, ancillary device, and other). The modified Rankin Scale (mRS) was used as a marker of clinical outcome.
Each of the 109 patients had 1 aneurysm suitable for WEB treatment (109 aneurysms). Three patients had 2 procedures, making a total of 112 procedures performed. Eight procedures were abandoned because of access issues; 2 patients went on to have a successful procedure. All 109 patients had a preprocedure and discharge mRS scores recorded. One hundred patients had a recorded mRS score from a > 3-month follow-up.
Deployment of the WEB device was successful in 103 (94.5%) of 109 patients and 104 (92.9%) of 112 procedures. One patient had 2 successful WEB procedures on separate occasions. Patients without a successfully implanted WEB device were included in the analysis. Selection analysis showed that the average patient age was 56.5 years among 34 men and 75 women. The percentage of incidental aneurysms was 58.7%, acute 16.5%, symptomatic 18.3%, and recurrent 6.4%. Further results analysis showed that 40 (36.7%) of 109 patients had recorded adverse events, including those unrelated to the WEB device. Events that could be related to the WEB device numbered 17 (15.6%) among the 109 patients. Two patients with device-related complications were symptomatic. Overall, 11 patients (10.1%) had persistent clinical sequelae. Thromboembolism was the most prevalent event, affecting 15.6% of the patients (17 of 109), and 6.4% of the patients (7 of 109) with a thromboembolism were symptomatic.
Overall mortality before discharge was 0% and at the > 3-month follow-up was 5% (5 of 100 patients). Morbidity was defined as an mRS score increase to > 2. Overall morbidity at discharge was 1.8% (2 of 109) and at the > 3-month follow-up was 6% (6 of 100). No device-related morbidity or mortality was associated with this group.
The UK data show that the WEB device is safe for clinical use. Thromboembolic complication adds a risk that should be minimized with appropriate anticoagulation and correct sizing of the device. There is scope for further evaluation and standardization of an anticoagulation regimen for the WEB device.
ABBREVIATIONSDL = double layer; ISAT = International Subarachnoid Aneurysm Trial; MCA = middle cerebral artery; mRS = modified Rankin Scale; SAH = subarachnoid hemorrhage; SL = single layer; SLS = single-layer sphere; UK = United Kingdom; WEB = Woven EndoBridge.
Correspondence Tufail Patankar, Department of Neurosurgery, Leeds Teaching Hospitals NHS Trust, Great George St., Leeds LS1 3EX, United Kingdom. email: email@example.com.
INCLUDE WHEN CITING Published online February 3, 2017; DOI: 10.3171/2016.9.JNS152849.
Disclosures Dr. Gholkar is a consultant for Sequent Medical. Dr. Lamin has a consulting and training contract with Covidien, Sequent Medical, and Medtronic. Dr. Molyneux is a consultant for Sequent Medical. Dr. Patankar is a consultant for Sequent Medical, Stryker, and Pulsar Vascular and has received funding from Sequent Medical for statistical analysis in this study. Dr. Sellar is a consultant for Sequent Medical. Sequent Medical funded Axiom Fusion eClinical Suite to build the WEB UK study database and provided funding for the statistical analysis.
BehmeD, BerlisA, WeberW: Woven EndoBridge intrasaccular flow disrupter for the treatment of ruptured and unruptured wide-neck cerebral aneurysms: report of 55 cases. 36:1501–1506, 20152595376110.3174/ajnr.A4323)| false
ChiuAHCheungAKWenderothJDDe VilliersLRiceHPhatourosCC: Long-term follow-up results following elective treatment of unruptured intracranial aneurysms with the Pipeline embolization device. AJNR Am J Neuroradiol36:1728–17342015
FargenKM, MoccoJ, NealD, DewanMC, Reavey-CantwellJ, WooHH, : A multicenter study of stent-assisted coiling of cerebral aneurysms with a Y configuration. 73:466–472, 201310.1227/NEU.0000000000000015)| false
GherasimDNGoryBSivan-HoffmannRPierotLRaoultHGauvritJY: Endovascular treatment of wide-neck an terior communicating artery aneurysms using WEB-DL and WEB-SL: short-term results in a multicenter study. AJNR Am J Neuroradiol36:1150–11542015
GherasimDN, GoryB, Sivan-HoffmannR, PierotL, RaoultH, GauvritJY, : Endovascular treatment of wide-neck an terior communicating artery aneurysms using WEB-DL and WEB-SL: short-term results in a multicenter study. 36:1150–1154, 201510.3174/ajnr.A4282)| false
LawsonAGoddardTRossSTyagiADenizKPatankarT: Endovascular treatment of cerebral aneurysms using the Woven EndoBridge technique in a single center: preliminary results.. J Neurosurg[epub ahead of print April 15 2016. DOI: 10.3171/20154.JNS142456]
LawsonA, GoddardT, RossS, TyagiA, DenizK, PatankarT: Endovascular treatment of cerebral aneurysms using the Woven EndoBridge technique in a single center: preliminary results.. [epub ahead of print April 15, 2016. DOI: 10.3171/20154.JNS142456])| false
LawsonAL, ChandranA, PuthuranM, GoddardT, NahserH, PatankarT: Initial experience of coiling cerebral aneurysms using the new Comaneci device. 8:e32, 201610.1136/neurintsurg-2015-011726.rep26138730)| false
LubiczB, KlischJ, GauvritJY, SzikoraI, LeonardiM, LiebigT, : WEB-DL endovascular treatment of wide-neck bifurcation aneurysms: short- and midterm results in a European study. 35:432–438, 201410.3174/ajnr.A3869)| false
MolyneuxAKerrRStrattonISandercockPClarkeMShrimptonJ: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet360:1267–12742002
PierotLCognardCSpelleLMoretJ: Safety and efficacy of balloon remodeling technique during endovascular treatment of intracranial aneurysms: critical review of the literature. AJNR Am J Neuroradiol33:12–152012
PierotL, CognardC, SpelleL, MoretJ: Safety and efficacy of balloon remodeling technique during endovascular treatment of intracranial aneurysms: critical review of the literature. 33:12–15, 201210.3174/ajnr.A240321349960)| false
PierotLKlischJCognardCSzikoraIMineBKadziolkaK: Endovascular WEB flow disruption in middle cerebral artery aneurysms: preliminary feasibility, clinical, and anatomical results in a multicenter study. Neurosurgery73:27–352013
PierotLLiebigTSychraVKadziolkaKDornFStrasillaC: Intrasaccular flow-disruption treatment of intracranial aneurysms: preliminary results of a multicenter clinical study. AJNR Am J Neuroradiol33:1232–12382012
PierotLMoretJTurjmanFHerbreteauDRaoultHBarreauX: WEB treatment of intracranial aneurysms: feasibility, complications, and 1-month safety results with the WEB DL and WEB SL/SLS in the French Observatory. AJNR Am J Neuroradiol36:922–9272015
PierotL, MoretJ, TurjmanF, HerbreteauD, RaoultH, BarreauX, : WEB treatment of intracranial aneurysms: feasibility, complications, and 1-month safety results with the WEB DL and WEB SL/SLS in the French Observatory. 36:922–927, 201510.3174/ajnr.A423025655876)| false
PierotLSpelleLMolyneuxAByrneJ: Clinical and anatomical follow-up in patients with aneurysms treated with the WEB device: 1-year follow-up report in the cumulated population of 2 prospective, multicenter series (WEBCAST and French Observatory). Neurosurgery78:133–1412016
PierotL, SpelleL, MolyneuxA, ByrneJ: Clinical and anatomical follow-up in patients with aneurysms treated with the WEB device: 1-year follow-up report in the cumulated population of 2 prospective, multicenter series (WEBCAST and French Observatory). 78:133–141, 201610.1227/NEU.000000000000110626552042)| false
VlakMHAlgraABrandenburgRRinkelGJ: Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol10:626–6362011
VlakMH, AlgraA, BrandenburgR, RinkelGJ: Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. 10:626–636, 201110.1016/S1474-4422(11)70109-021641282)| false
WallnerAK, BroussalisE, HauserT, TrinkaE, Killer-OberpfalzerM: Coiling after treatment with the woven EndoBridge cerebral aneurysm embolization device. A case report. 18:208–212, 20122268173810.1177/159101991201800214)| false